EXHIBIT 10.69
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT, dated as of March 31, 2003 between
Talisman Management Limited ("Purchaser") and Viragen, Inc. (the "Company").
WHEREAS, simultaneously with the execution and delivery of this
Agreement, pursuant to a Common Stock Purchase Agreement dated the date hereof
(the "Purchase Agreement") the Purchaser has committed to purchase up to
$12,000,000 of the Company's Common Stock (TERMS NOT DEFINED HEREIN SHALL HAVE
THE MEANINGS ASCRIBED TO THEM IN THE PURCHASE AGREEMENT); and
WHEREAS, the Company desires to grant to the Purchaser the
registration rights set forth herein with respect to the Draw Down Shares and
the Warrant Shares (collectively, the "Securities").
NOW, THEREFORE, the parties hereto mutually agree as follows:
Section 1. Registrable Securities. As used herein the term
"Registrable Security" means the Securities; provided, however, that any shares
of Common Stock which are Registrable Securities shall cease to be Registrable
Securities (i) when sold pursuant to the Registration Statement, (ii) when sold
pursuant to Rule 144 (or any similar provision then in force) under the
Securities Act ("Rule 144"), (iii) upon any sale in any manner to a person or
entity which is not entitled pursuant to Section 9 to rights under this
Agreement, or (iv) such time as, in the opinion of counsel to the Company, such
Securities may be sold without any time, volume or manner limitations pursuant
to Rule 144(k) (or any similar provision then in effect) under the Securities
Act. In the event of any merger, reorganization, consolidation,
recapitalization or other change in corporate structure affecting the Common
Stock, such adjustment shall be deemed to be made in the definition of
"Registrable Security" as is appropriate in order to prevent any dilution or
enlargement of the rights granted pursuant to this Agreement.
Section 2. Restrictions on Transfer. The Purchaser acknowledges and
understands that in the absence of an effective Registration Statement
authorizing the resale of the Securities as provided herein, the Securities are
"restricted securities" as defined in Rule 144. The Purchaser understands that
no disposition or transfer of the Securities may be made by Purchaser in the
absence of (i) an opinion of counsel to the Purchaser, in form and substance
reasonably satisfactory to the Company, that such transfer may be made without
registration under the Securities Act or (ii) such registration.
With a view to making available to the Purchaser the benefits of Rule
144, the Company agrees:
(a) to comply with the provisions of paragraph (c)(1) of Rule
144; and
(b) to use its best effort to file with the Securities and
Exchange Commission (the "Commission") in a timely manner all reports
and other documents required to be filed by the Company pursuant to
Section 13 or 15(d) under the Exchange Act; and furnish the Purchaser
with such other reports and documents of the Company as the Purchaser
may reasonably request to avail itself of any similar rule or
regulation of the Commission allowing it to sell any such securities
without registration.
Section 3. Registration Rights With Respect to the Securities.
(a) The Company agrees that it will prepare and file with the
Commission, within the earlier of (i) 20 days after the effectiveness
of the registration statement currently on file with the Commission and
(ii) forty-five days after the date hereof, a registration statement
(on Form S-1, or other appropriate form of registration statement)
under the Securities Act (the "Registration Statement"), at the sole
expense of the Company (except as provided in Section 3(c) hereof), in
respect of Purchaser, so as to permit a public offering and resale of
the Securities under the Securities Act by Purchaser. The Company shall
use its commercially reasonable efforts to cause the Registration
Statement to become effective within 90 days of the date hereof or five
(5) days of clearance by the Commission and will within said five (5)
days request acceleration of effectiveness of the Registration
Statement by the Commission. The Company will notify Purchaser of the
effectiveness of the Registration Statement within one Trading Day of
such event.
(b) The Company will maintain the Registration Statement or
post-effective amendment filed under this Section 3 hereof effective
under the Securities Act until the earliest of (i) the date that all
the Registrable Securities have been disposed of pursuant to the
Registration Statement, (ii) 360 days from the last date Registrable
Securities are issued, (iii) the date that all of the Securities may be
sold under the provisions of Rule 144, (iv) the date all Securities
have been otherwise transferred to persons who may trade such shares
without restriction under the Securities Act, and the Company has
delivered a new certificate or other evidence of ownership for such
Securities not bearing a restrictive legend, or (v) the date all
Securities may be sold without any time, volume or manner limitations
pursuant to Rule 144(k) or any similar provision then in effect under
the Securities Act (the "Effectiveness Period").
(c) All fees, disbursements and out-of-pocket expenses and costs
incurred by the Company in connection with the preparation and filing
of the Registration Statement under subparagraph 3(a) and in complying
with applicable securities and Blue Sky laws (including, without
limitation, all attorneys' fees of the Company) shall be borne by the
Company. The Purchaser shall bear the cost of underwriting and/or
brokerage discounts, fees and commissions, if any, applicable to the
Securities being registered and the fees and expenses of its counsel.
The Purchaser and its counsel shall have a reasonable period, not to
exceed three (3) Trading Days, to review the proposed Registration
Statement or any amendment thereto, prior to filing with the
Commission,
2
and the Company shall provide the Purchaser with copies of any comment
letters received from the Commission with respect thereto within two
(2) Trading Days of receipt thereof. The Company shall make reasonably
available for inspection by Purchaser, any underwriter participating in
any disposition pursuant to the Registration Statement, and any
attorney, accountant or other agent retained by the Purchaser or any
such underwriter all relevant financial and other records, pertinent
corporate documents and properties of the Company and its subsidiaries,
and cause the Company's officers, directors and employees to supply all
information reasonably requested by the Purchaser or any such
underwriter, attorney, accountant or agent in connection with the
Registration Statement; provided, however, that all records,
information and documents that are designated in writing by the Company
as confidential, proprietary or containing any material non-public
information shall be kept confidential by the Purchaser and any such
underwriter, attorney, accountant or agent (pursuant to an appropriate
confidentiality agreement in the case of the Purchaser, underwriter,
attorney, accountant or agent), unless such disclosure is made pursuant
to judicial process in a court proceeding (after first giving the
Company an opportunity promptly to seek a protective order or otherwise
limit the scope of the information sought to be disclosed) or is
required by law, or such records, information or documents become
available to the public through a third party not in violation of an
accompanying obligation of confidentiality; and provided further that,
if the foregoing inspection and information gathering would otherwise
disrupt the Company's conduct of its business, such inspection and
information gathering shall, to the maximum extent possible, be
coordinated on behalf of the Purchaser and the other parties entitled
thereto by one firm of counsel designed by and on behalf of the
majority in interest of Purchaser and other parties. The Company at its
expense will supply the Purchaser with such reasonable number of copies
of the Registration Statement and the final prospectus included therein
(the "Prospectus") and other related documents as the Purchaser may
request in order to facilitate the public sale or other disposition of
the Registrable Securities.
(d) The Company shall not be required by this Section 3 to
include the Purchaser's Securities in any Registration Statement which
is to be filed if, in the opinion of counsel for both the Purchaser and
the Company (or, should they not agree, in the opinion of another
counsel experienced in securities law matters acceptable to counsel for
the Purchaser and the Company) the proposed offering or other transfer
as to which such registration is requested is exempt from applicable
federal and state securities laws and would result in all purchasers or
transferees obtaining securities which are not "restricted securities",
as defined in Rule 144 under the Securities Act.
If at any time or from time to time after the effective date of
the Registration Statement, the Company notifies the Purchaser in writing of
the existence of a Potential Material Event (as defined in Section 3(e) below),
the Purchaser shall not offer or sell any Securities or engage in any other
transaction involving or relating to Securities, from the time of the giving of
notice with respect to a Potential Material Event until the Purchaser has
received copies of a supplemented or amended Prospectus or until the Purchaser
is advised in writing by the Company that the then current Prospectus may be
used and has received copies of any additional or supplemental filings that are
3
incorporated or deemed incorporated by reference in such Prospectus
(the "Suspension Period"); provided, however, that, if a Suspension
Period occurs during any periods commencing on a Trading Day a Draw
Down Notice is deemed delivered and ending ten (10) Trading Days
following the end of the corresponding Draw Down Pricing Period, then
the Company must compensate the Purchaser for any net decline in the
market value of any Securities committed to be purchased by the
Purchaser through the end of such Suspension Period. Net decline shall
be calculated as the difference between the highest VWAP during the
applicable Suspension Period and the VWAP on the Trading Day
immediately following a properly delivered notice to the Purchaser that
such Suspension Period has ended. The Company must give Purchaser
notice in writing promptly upon knowledge that a Suspension Period may
occur without indicating the nature of such Suspension Period.
(e) "Potential Material Event" means any of the following: (i)
the possession by the Company of material information that is not ripe
for disclosure in a registration statement, as determined in good faith
by the Chief Executive Officer or the Board of Directors of the Company
or that disclosure of such information in the Registration Statement
would be detrimental to the business or affairs of the Company; or (ii)
any material engagement, development or activity by the Company which
would, in the good faith determination of the Chief Executive Officer
or the Board of Directors of the Company, be adversely affected by
disclosure in a registration statement at such time, which
determination shall be accompanied by a good faith determination by the
Chief Executive Officer or the Board of Directors of the Company that
the Registration Statement would be materially misleading absent the
inclusion of such information; or (iii) pursuant to applicable law, a
fundamental change that requires the Company to file a post-effective
amendment to the Registration Statement, change the plan of
distribution to the Prospectus, or must update the information included
in the Prospectus pursuant to Section 10(a)(3) of the Securities Act.
(f) If the Company has delivered a Prospectus to the Purchaser
and after having done so the Prospectus is amended to comply with the
requirements of the Securities Act, the Company shall promptly notify
the Purchaser and, if requested, the Purchaser shall immediately cease
making offers of Registrable Securities. The Company shall promptly
provide the Purchaser with revised Prospectuses and, following receipt
of the revised Prospectuses, the Purchaser shall be free to resume
making offers of the Registrable Securities.
Section 4. Cooperation with Company. The Purchaser will cooperate with
the Company in all respects in connection with this Agreement, including timely
supplying all information reasonably requested by the Company (which shall
include all information regarding the Purchaser and proposed manner of sale of
the Registrable Securities required to be disclosed in the Registration
Statement) and executing and returning all documents reasonably requested in
connection with the registration and sale of the Registrable Securities and
entering into and performing its obligations under any underwriting agreement,
if the offering is an underwritten offering, in usual and customary form, with
the managing underwriter or underwriters of such underwritten offering. The
Purchaser shall consent to be named as an underwriter in the
4
Registration Statement. Purchaser acknowledges that in accordance with current
Commission policy, the Purchaser will be named as the underwriter of the
Securities in the Registration Statement.
Section 5. Registration Procedures. If and whenever the Company is
required by any of the provisions of this Agreement to effect the registration
of any of the Registrable Securities under the Securities Act, the Company
shall (except as otherwise provided in this Agreement), as expeditiously as
possible, subject to the Purchaser's assistance and cooperation as reasonably
required:
(a) As expeditiously as possible prepare and file with the
Commission such amendments and supplements to the Registration
Statement and the Prospectus as may be necessary to keep such
Registration Statement effective until the end of the Effectiveness
Period and to comply with the provisions of the Securities Act with
respect to the sale or other disposition of all securities covered by
the Registration Statement (including prospectus supplements with
respect to the sales of securities from time to time in connection with
a registration statement pursuant to Rule 415 promulgated under the
Securities Act);
(b) prior to the filing with the Commission of any Registration
Statement (including any amendments thereto) and the distribution or
delivery of the Prospectus (including any supplements thereto), (i)
provide draft copies thereof to the Purchaser and reflect in such
documents all such comments as the Purchaser (and its counsel)
reasonably may propose and (ii) furnish to the Purchaser such numbers
of copies of the Prospectus including a preliminary prospectus or any
amendment or supplement to the Prospectus, as applicable, in conformity
with the requirements of the Securities Act, and such other documents,
as the Purchaser may reasonably request in order to facilitate the
public sale or other disposition of the Registrable Securities;
(c) as expeditiously as possible use its best efforts to
register or qualify the Registrable Securities covered by the
Registration Statement under the applicable blue sky laws as requested
by the Purchaser (subject to the limitations set forth in Section 3(c)
above), and do any and all other acts and things which may be
reasonably necessary or advisable to enable the Purchaser to consummate
the public sale or other disposition in such jurisdiction of the
Registrable Securities, except that the Company shall not for any such
purpose be required to qualify to do business as a foreign corporation
in any jurisdiction wherein it is not so qualified or to execute any
general consent to service of process;
(d) list such Registrable Securities on the Principal Market,
and any other exchange on which the Common Stock of the Company is then
listed, if the listing of such Registrable Securities is then permitted
under the rules of such exchange or the Principal Market;
(e) notify the Purchaser at any time when the Prospectus is
required to be delivered under the Securities Act, of the happening of
any event of which it has
5
knowledge as a result of which the Prospectus, as then in effect,
includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances
then existing, and the Company shall prepare and file a curative
amendment or curative supplement under Section 5(a) as quickly as
commercially possible and the period beginning on the date of notice
until the curative amendment is effective or curative supplement is
provided to the Purchaser shall be deemed a Suspension Period and the
Company shall compensate the Purchaser as set forth in Section 3(d)
herein;
(f) as promptly as practicable after becoming aware of such
event, notify the Purchaser (or, in the event of an underwritten
offering, the managing underwriters) of the issuance by the Commission
or any state authority of any stop order or other suspension of the
effectiveness of the Registration Statement and use commercially
reasonable efforts to effect the withdrawal, rescission or removal of
such stop order or other suspension; and
(g) maintain a transfer agent for its Common Stock.
Section 6. Indemnification.
(a) The Company agrees to indemnify and hold harmless the
Purchaser and each person, if any, who controls the Purchaser within
the meaning of the Securities Act ("Distributing Purchaser") against
any losses, claims, damages or liabilities, joint or several (which
shall, for all purposes of this Agreement, include, but not be limited
to, all reasonable costs of defense and investigation and all
reasonable attorneys' fees incurred by the Distributing Purchaser), to
which the Distributing Purchaser may become subject, under the
Securities Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) (i) arise out of or are
based upon any untrue statement or alleged untrue statement of any
material fact contained in the Registration Statement, or any related
preliminary prospectus, the Prospectus or amendment or supplement to
such Registration Statement, or (ii) arise out of or are based upon the
omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not
misleading; provided, however, that the Company will not be liable in
any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged
untrue statement or omission or alleged omission made in the
Registration Statement, preliminary prospectus, the Prospectus or
amendment or supplement to the Registration Statement in reliance upon,
and in conformity with, written information furnished to the Company by
the Distributing Purchaser specifically for use in the preparation
thereof. This Section 6(a) shall not inure to the benefit of any
Distributing Purchaser with respect to any person asserting such loss,
claim, damage or liability who purchased the Registrable Securities
which are the subject thereof if the Distributing Purchaser failed to
send or give (in violation of the Securities Act or the rules and
regulations promulgated thereunder) a copy of the Prospectus to such
person at or prior to the written confirmation to such person of the
sale of such Registrable Securities, where the Distributing Purchaser
was obligated to do so under the Securities Act or the rules and
regulations promulgated
6
thereunder. This indemnity agreement will be in addition to any
liability which the Company may otherwise have.
(b) The Purchaser agrees that it will indemnify and hold
harmless the Company, and each officer, director of the Company or
person, if any, who controls the Company within the meaning of the
Securities Act, against any losses, claims, damages or liabilities
(which shall, for all purposes of this Agreement, include, but not be
limited to, all reasonable costs of defense and investigation and all
reasonable attorneys' fees incurred by the Purchaser) to which the
Company or any such officer, director or controlling person may become
subject under the Securities Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise
out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained in the Registration Statement,
or any related preliminary prospectus, the Prospectus or amendment or
supplement to the Registration Statement, or arise out of or are based
upon the omission or the alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements
therein not misleading, but in each case only to the extent that such
untrue statement or alleged untrue statement or omission or alleged
omission was made in the Registration Statement, preliminary
prospectus, the Prospectus or amendment or supplement thereto in
reliance upon, and in conformity with, written information furnished to
the Company by such Purchaser specifically for use in the preparation
thereof. This indemnity agreement will be in addition to any liability
which the Purchaser may otherwise have. Notwithstanding anything to the
contrary herein, the Purchaser shall not be liable under this Section
6(b) for any amount in excess of the net proceeds to such Purchaser as
a result of the sale of Registrable Securities pursuant to the
Registration Statement.
(c) Promptly after receipt by an indemnified party under this
Section 6 of notice of the commencement of any action as to which
indemnity may be sought under this Section 6, notify the indemnifying
party of the commencement thereof and shall permit the indemnifying
party to assume the defense of any claim or any litigation resulting
therefrom; provided, that counsel for the indemnifying party, who shall
conduct the defense of such claim or litigation, shall be approved by
the indemnified party (whose approval shall not be unreasonably
withheld, conditioned or delayed); but the failure to notify the
indemnifying party will not relieve the indemnifying party from any
obligations which it may have to any indemnified party except to the
extent of actual prejudice demonstrated by the indemnifying party.
After notice from the indemnifying party to such indemnified party of
its election so to assume the defense thereof, the indemnifying party
will not be liable to such indemnified party under this Section 6 for
any legal or other expenses subsequently incurred by such indemnified
party in connection with the defense thereof other than reasonable
costs of investigation, unless the indemnifying party shall not pursue
the action to its final conclusion. The indemnified party shall have
the right, at such party's own expense, to employ separate counsel in
any such action and to participate in the defense thereof; provided
that the indemnifying party shall pay such expense if: (i) the
employment of such counsel has been specifically authorized in writing
by the indemnifying party, or (ii) the named parties to any such action
(including any impleaded parties) include both the indemnified party
and the indemnifying party and the
7
indemnified party reasonably concludes that representation of such
indemnified party by the counsel retained by the indemnifying party
would be inappropriate due to actual or potential differing interests
between the indemnified party and any other party represented by such
counsel in such proceeding; provided further that in no event shall the
indemnifying party be required to pay the expenses of more than one law
firm per jurisdiction as counsel for the indemnified party. No
indemnifying party, in the defense of any such claim or litigation
shall, except with the consent of each indemnified party, consent to
entry of any judgment or enter into any settlement which does not
include as an unconditional term thereof the giving by the claimant or
plaintiff to such indemnified party of a release from all liability in
respect of such claim or litigation, and no indemnified party shall
consent to entry of any judgment or settle such claim or litigation
without the prior written consent of the indemnifying party, which
consent shall not be unreasonably withheld, conditioned or delayed.
(d) If the indemnifying party does not assume the defense of any
claim or litigation pursuant to this Section 6, all reasonable costs of
defense and investigation in a manner not inconsistent with this
Section and all reasonable attorneys' fees incurred by the indemnified
party in connection with a claim or litigation covered by this Section
6 shall be paid to the indemnified party, as incurred, within ten (10)
Trading Days of written notice thereof to the indemnifying party;
provided, that the indemnifying party may require such indemnified
party to undertake to reimburse all such fees and expenses to the
extent it is finally judicially determined that such indemnified party
is not entitled to indemnification hereunder.
Section 7. Contribution.
(a) In order to provide for just and equitable contribution
under the Securities Act in any case in which (i) the indemnified party
makes a claim for indemnification pursuant to Section 6 hereof but is
judicially determined (by the entry of a final judgment or decree by a
court of competent jurisdiction and the expiration of time to appeal or
the denial of the last right of appeal) that such indemnification may
not be enforced in such case notwithstanding the fact that the express
provisions of Section 6 hereof provide for indemnification in such
case, or (ii) contribution under the Securities Act may be required on
the part of any indemnified party, then the Company and the Purchaser
shall contribute to the aggregate losses, claims, damages or
liabilities to which they may be subject (which shall, for all purposes
of this Agreement, include, but not be limited to, all reasonable costs
of defense and investigation and all reasonable attorneys' fees), in
either such case (after contribution from others) on the basis of
relative fault as well as any other relevant equitable considerations.
The relative fault shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company on the one hand or the
applicable Distributing Purchaser on the other hand, and the parties'
relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Company and the
Purchaser agree that it would not be just and equitable if contribution
pursuant to this Section 7 were determined by pro rata allocation or by
any other method
8
of allocation which does not take account of the equitable
considerations referred to in this Section 7. The amount paid or
payable by an indemnified party as a result of the losses, claims,
damages or liabilities (or actions in respect thereof) referred to
above in this Section 7 shall be deemed to include any legal or other
expenses reasonably incurred by such indemnified party in connection
with investigating or defending any such action or claim. No person
guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation. Any
party entitled to contribution will, promptly after receipt of notice
of commencement of any action, suit or proceeding against such party in
respect of which a claim for contribution may be made against another
party or parties under this Section 7, notify such party or parties
from whom contribution may be sought, but the omission so to notify
such party or parties from whom contribution may be sought shall not
relieve such party from any other obligation it or they may have
thereunder or otherwise under this Section 7. No party shall be liable
for contribution with respect to any action, suit, proceeding or claim
settled without its prior written consent, which consent shall not be
unreasonably withheld, conditioned or delayed.
(b) Notwithstanding any other provision of this Section 7, in no
event shall any (i) Purchaser be required to undertake liability to any
person under this Section 7 for any amounts in excess of the dollar
amount of the gross proceeds to be received by the Purchaser from the
sale of the Purchaser's Registrable Securities pursuant to any
Registration Statement under which such Registrable Securities are to
be registered under the Securities Act and (ii) underwriter be required
to undertake liability to any person hereunder for any amounts in
excess of the aggregate discount, commission or other compensation
payable to such underwriter with respect to the Registrable Securities
underwritten by it and distributed pursuant to the Registration
Statement.
Section 8. Notices. All notices, demands, requests, consents,
approvals, and other communications required or permitted hereunder shall be in
writing and, unless otherwise specified herein, shall be delivered as set forth
in the Purchase Agreement.
Section 9. Assignment. Neither this Agreement nor any rights of the
Purchaser or the Company hereunder may be assigned by either party to any other
person. Notwithstanding the foregoing, (a) the provisions of this Agreement
shall inure to the benefit of, and be enforceable by, any transferee of any of
the Common Stock purchased by the Purchaser pursuant to the Purchase Agreement
other than through open-market sales, and (b) upon the prior written consent of
the Company, which consent shall not be unreasonably withheld or delayed in the
case of an assignment to an affiliate of the Purchaser, the Purchaser's
interest in this Agreement may be assigned at any time, in whole or in part, to
any other person or entity (including any affiliate of the Purchaser) who
agrees to be bound hereby.
Section 10. Counterparts/Facsimile. This Agreement may be executed in
two or more counterparts, each of which shall constitute an original, but all
of which, when together shall constitute but one and the same instrument, and
shall become effective when one or more counterparts have been signed by each
party hereto and delivered to the other party. In lieu of the
9
original, a facsimile transmission or copy of the original shall be as
effective and enforceable as the original.
Section 11. Remedies and Severability. The remedies provided in this
Agreement are cumulative and not exclusive of any remedies provided by law. If
any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth
herein shall remain in full force and effect and shall in no way be affected,
impaired or invalidated, and the parties hereto shall use their best efforts to
find and employ an alternative means to achieve the same or substantially the
same result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the intention of the
parties that they would have executed the remaining terms, provisions,
covenants and restrictions without including any of those that may be hereafter
declared invalid, illegal, void or unenforceable.
Section 12. Conflicting Agreements. The Company shall not enter into
any agreement with respect to its securities that is inconsistent with the
rights granted to the Purchasers in this Agreement or otherwise prevents the
Company from complying with all of its obligations hereunder.
Section 13. Headings. The headings in this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of
this Agreement.
Section 14. Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of New York applicable to
contracts made in New York by persons domiciled in New York City and without
regard to its principles of conflicts of laws. The Company and the Purchaser
agree to submit themselves to the in personam jurisdiction of the state and
federal courts situated within the Southern District of the State of New York
with regard to any controversy arising out of or relating to this Agreement.
Any party shall have the right to seek injunctive relief from any court of
competent jurisdiction in any case where such relief is available.
***************************
10
[REGISTRATION RIGHTS AGREEMENT SIGNATURE PAGE]
IN WITNESS WHEREOF, the parties hereto have caused this Registration
Rights Agreement to be duly executed as of the date set forth above.
VIRAGEN, INC.
By: /s/ Xxxxxx X. Xxxxxx
------------------------------------
Name: Xxxxxx X. Xxxxxx
Title: Executive Vice President and
Chief Financial Officer
TALISMAN MANAGEMENT LIMITED
By: /s/ Xxxxxx X. Xxxxx
------------------------------------
Name: Xxxxxx X. Xxxxx
Title: Director
11
